Search: 2018 EU Meeting Faculty
Results 1 - 7 of 7

Steven Walker

Director and Co-Owner
St Gilesmedical London & Berlin

Type of Company:
Communications Agency
Professional Degrees: MD, MEd, MS
CMPP Certified: (3/2016)

Bio: Steven has degrees in medicine, education and clinical oncology. He trained in the UK, USA and Germany. His focus is on building St Gilesmedical's team of medics, scientists, writers and educators in London and Berlin into a major health communication company. Current interests include medical and regulatory writing, teaching and delivery of effective meetings. Steven is active in ISMPP, EMWA and lectures at Manchester Metropolitan University. St Gilesmedical also supports non-commercial education and research activities in the UK and Germany. The needs of patients and healthcare professionals are at the centre of everything we do.

Al Weigel

CMPP Certified: (2/2009)

Bio: Al Weigel is President and COO for the International Society for Medical Publication Professionals (ISMPP). Al joined ISMPP in November of 2013 with primary responsibility for implementing the strategic goals and vision of the Society, in addition to ensuring the Society meets established milestones for ongoing development, growth and success. Prior to joining ISMPP, Al led cross-therapeutic medical publication and scientific communication teams at sanofi-aventis, Boehringer-Ingelheim and Celgene Corporation. Al earned his Masters of Education at the University of the Arizona and currently is a ISMPP Certified Medical Publication Professional (CMPP).

Richard White

Chief Operating Officer
Oxford PharmaGenesis Ltd

Type of Company:
Communications Agency
Professional Degrees: MA, PhD

Bio: Richard White is Chief Operating Officer at Oxford PharmaGenesis, an independent HealthScience communications consultancy. He has more than 20 years of experience in medical communications, and has led launch publications plans for products across a broad range of therapy areas. Richard is a member of the International Society for Medical Publications Professionals (ISMPP), the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the Institute of Directors. He was a reviewer of the GPP2 and GPP3 guidelines, and has personally authored more than 20 journal publications. Richard has published white papers on good publication practice, value demonstration and rare diseases in Pharmaceutical Marketing Europe, is an invited author of articles for ISMPP's MAP e-newsletter, and is on the Editorial Board of Drugs in Context. Richard founded the Oxford PharmaGenesis Value Demonstration Practice to apply good publication practice and communications expertise to HEOR, RWE and patient-reported outcomes (PRO) studies. He has run training workshops in these areas for multiple pharma companies and academic institutions, and has delivered invited presentations, educational webinars and moderated roundtable discussions on publications and communications best practice in HEOR, RWE and PROs at the ISMPP and TIPPA Annual Meetings, the World Orphan Drug Congress, and the Patient Summit. Richard was Chair of the 2017 and 2018 TIPPA Annual Meetings. Before joining Oxford PharmaGenesis, Richard gained his MA and PhD in Natural Sciences from the University of Cambridge, UK. His PhD research won the 1998 Glaxo Wellcome Young Investigator's Award, and he was awarded a Research Fellowship in Pharmacology at Sidney Sussex College, Cambridge. He has completed the Advanced Health Economic Modeling Programme at the University of Oxford, is an alumnus of the International Marketing Programme at INSEAD, and is a member of Green Templeton College, University of Oxford, UK.

Witold Wiecek

Statistical Project Manager
Analytica Laser

Bio: Witold Wiecek, is a Statistical Project Manager at Analytica Laser, Witold is currently a technical lead for HOPE: LASER's proprietary tool for modelling real-world effectiveness, as well as working and publishing on Bayesian inference models, survival analysis, network meta-analyses, and infectious disease modelling.

Jurgen Wiehn

Senior Director, Medical Affairs
Avexis GmbH

Type of Company:
Professional Degrees: CMPP, PhD
CMPP Certified: (9/2011)

Bio: Jurgen, PhD, ISMPP CMPP, has over 15 years of international pharmaceutical/biotech experience in medical affairs and clinical development (Publications/Scientific and Regulatory Writing; Medical Information, Communication and Education). Prior to industry career, Jurgen studied biology, gained his PhD in Finland and lead academic research programs in Finland and Switzerland. His industry experience comes from Orion Pharma, Merck Serono, Ferring Pharmaceuticals, Shire and, most recently, from Shire, where Jurgen works as a Senour Director, EMEA Medical Communications and Publications since 2018.

David Williams

Global engagement lead Real World Data and Analytics

Bio: David is a physician with 10 years' clinical experience in primary and secondary care in the UK and Australia, as well as over 17 years as a pharmaceutical physician with a specific interest in the medical role in health policy and market access. David has provided medical leadership in numerous launch teams, lead successful HTA submissions and has a wide therapeutic experience. In addition to 12 years of medical roles including regional and affiliate level leadership roles, he has also roles in as Head of HEOR for Global R&D AstraZeneca as well as Global Head of Government Affairs in AZ. In addition to his medical degree, David is also a Masters graduate in Heath Economics and Evidence-Based Medicine. David joined Sanofi in 2015 as Medical Director and then Country Medical Chair in the UK & Ireland, and since April 2016 has been Global Head of Medical Education and Scientific Communications reporting to Dr Sandra Silvestri in GEM. He has been married to Ruth for 25 years and they have two sons: Felix and Seth.

Christopher Winchester

Chief Executive Officer
Oxford PharmaGenesis

Type of Company:
Communications Agency
Professional Degrees: BA/BS, PhD

Bio: Chris Winchester is Chief Executive Officer of Oxford PharmaGenesis, an independent HealthScience communications consultancy with a strong heritage in publications. Now in its 21st year, Oxford PharmaGenesis employs over 250 communications professionals in Europe, North America and Asia Pacific. Chris is Chair of ISMPP, a founder of Open Pharma, led the development of the AMWA-EMWA-ISMPP Joint Position Statement on the role of the professional medical writer, and has been involved in collaborative research on the value of professional medical writing support. He has a doctorate in Biochemistry, has co-authored articles in the fields of cardiology, gastroenterology and respiratory medicine, and is an Associate Member of Green Templeton College at the University of Oxford.